GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3D Global Biotech Inc (ROCO:6808) » Definitions » Net Income (Continuing Operations)

3D Global Biotech (ROCO:6808) Net Income (Continuing Operations) : NT$-57.95 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is 3D Global Biotech Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. 3D Global Biotech's Net Income (Continuing Operations) for the six months ended in Dec. 2023 was NT$-27.70 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-57.95 Mil.

3D Global Biotech Net Income (Continuing Operations) Historical Data

The historical data trend for 3D Global Biotech's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3D Global Biotech Net Income (Continuing Operations) Chart

3D Global Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income (Continuing Operations)
Get a 7-Day Free Trial -36.32 -47.92 -59.71 -67.09 -57.95

3D Global Biotech Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.96 -32.78 -34.31 -30.26 -27.70

3D Global Biotech Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-57.95 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

3D Global Biotech  (ROCO:6808) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

3D Global Biotech Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of 3D Global Biotech's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

3D Global Biotech (ROCO:6808) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3D Global Biotech Inc (ROCO:6808) » Definitions » Net Income (Continuing Operations)
Comparable Companies
ROCO:6549 ROCO:6814 ROCO:6917 ROCO:3118 ROCO:4732 ROCO:6236 ROCO:6652 ROCO:4131 ROCO:6662 ROCO:4192 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
No.99, Sec. 1, Xintai 5th Rd, 21st Floor -3, Xizhi District, New Taipei, TWN, 221
Website
http://www.3dglobalbiotech.com.tw
3D Global Biotech Inc is engaged in developing reconstruction of human tissues and organs and manufactures customized and personalized high-level medical devices.

3D Global Biotech (ROCO:6808) Headlines

No Headlines